progress in drug research vol. 67
Share
epigenetics and disease
Susan M. Gasser
(Illustrated by)
·
En Li
(Illustrated by)
·
Springer
· Paperback
epigenetics and disease - Gasser, Susan M. ; Li, En
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My Wishlists
Origin: U.S.A.
(Import costs included in the price)
It will be shipped from our warehouse between
Friday, July 19 and
Friday, July 26.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "epigenetics and disease"
epigenetics has emerged recently as an important area of molecular biological studies. epigenetic modifications lead to potentially heritable but reversible alterations in the expression of genes that determine cell fate. epigenetic misregulation is thus often linked to degenerative diseases, cancer and neuronal disorders. recent biomedical interest in this regulatory system stems from the fact that epigenetic, in contrast to genetic, alterations are in principle amenable to pharmacological intervention. a few epigenetically active drugs, for example histone deacetylase inhibitors (hdaci) and dna methyltransferase (dnmt) inhibitors, have been approved by fda for treatment of cancers such as ctcl, mds, and aml. this volume explores the scientific background for clinical applications of epigenetically active drugs. included are descriptions of epigenetic controls over gene expression, the post-transcriptional silencing of genes by rna interference (rnai) and micrornas, as well as new findings from stem cell research which are relevant to pharmacological applications.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.
✓ Producto agregado correctamente al carro, Ir a Pagar.
